TY - JOUR AU - Blanc, R. AU - Fahed, R. AU - Roux, P. PY - 2018 DA - 2018// TI - Augmented 3D venous navigation for neuroendovascular procedures JO - J Neurointervent Surg VL - 10 UR - https://doi.org/10.1136/neurintsurg-2017-013365 DO - 10.1136/neurintsurg-2017-013365 ID - Blanc2018 ER - TY - JOUR AU - Boddu, S. AU - Dinkin, M. AU - Suurna, M. AU - Hannsgen, K. AU - Bui, X. AU - Patsalides, A. PY - 2016 DA - 2016// TI - Resolution of pulsatile tinnitus after venous sinus stenting in patients with idiopathic intracranial hypertension JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0164466 DO - 10.1371/journal.pone.0164466 ID - Boddu2016 ER - TY - JOUR AU - Daggubati, L. C. AU - Liu, K. C. PY - 2019 DA - 2019// TI - Intracranial venous sinus stenting: a review of idiopathic intracranial hypertension and expanding indications JO - Cureus. VL - 11 ID - Daggubati2019 ER - TY - JOUR AU - Dinkin, M. J. AU - Patsalides, A. PY - 2017 DA - 2017// TI - Venous sinus stenting for idiopathic intracranial hypertension: where are we now? JO - Neurol Clin VL - 35 UR - https://doi.org/10.1016/j.ncl.2016.08.006 DO - 10.1016/j.ncl.2016.08.006 ID - Dinkin2017 ER - TY - JOUR AU - Kalyvas, A. V. AU - Hughes, M. AU - Koutsarnakis, C. PY - 2017 DA - 2017// TI - Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature JO - Acta Neurochir VL - 159 UR - https://doi.org/10.1007/s00701-016-3010-2 DO - 10.1007/s00701-016-3010-2 ID - Kalyvas2017 ER - TY - JOUR AU - Lavoie, P. AU - Audet, M. AU - Gariepy, J. L. PY - 2018 DA - 2018// TI - Severe cerebellar hemorrhage following transverse sinus stenting for idiopathic intracranial hypertension JO - Intervent Neuroradiol VL - 24 UR - https://doi.org/10.1177/1591019917734389 DO - 10.1177/1591019917734389 ID - Lavoie2018 ER - TY - JOUR AU - Smith-Bindman, R. AU - Lipson, J. AU - Marcus, R. PY - 2009 DA - 2009// TI - Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer JO - Arch Intern Med VL - 169 UR - https://doi.org/10.1001/archinternmed.2009.427 DO - 10.1001/archinternmed.2009.427 ID - Smith-Bindman2009 ER - TY - STD TI - Woolen SA, Shankar PR, Gagnier JJ, MacEachern MP, Singer L, Davenport MS. Risk of Nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis. JAMA Intern Med. 2019;180(2):223–30. https://doi.org/10.1001/jamainternmed.2019.5284. ID - ref8 ER -